TrialBMC cancer2019

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial.

Liang-Cheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.